A new study released by our 2016-17 Seed Grant Awardee, Nada Kalaany, PhD shows evidence that targeting an enzyme that tumors use to get rid of nitrogen can slow tumor growth. These innovative therapeutic strategies are precisely why our Seed Grant Program is crucial in the fight against pancreatic cancer.
Chemotherapy nanoparticles offer breakthrough in pancreatic cancer drug delivery
Originally published at http://www.cancer.ucla.edu UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer Study shows the peptide enhances a […]
13th Annual Symposium Video Presentations
We’re happy to announce that the video presentations of the 13th annual Symposium on Pancreatic Cancer are now available to view on our website. This year the Symposium was titled, […]
Study Explains Genetic Connection Between Aging and Cancer
David Gius, MD, PhD from Northwestern University was funded in the 2012 cycle of the Hirshberg Foundation’s annual Seed Grant Program. The results of the study explain the genetic connection […]
Hirshberg Funded International Researcher Publishes Findings
2011 Seed Grant Recipient Ido Wolf, MD from University of Tel Aviv, Israel, recently published his findings that will offer novel approaches towards development of new therapies for pancreatic cancer. […]
Richard Hatch Memorial Fund
Richard Hatch, star of the original “Battlestar Galatica” passed away on February 7, 2017 after a battle with pancreatic cancer. Hatch was best known for his role as Captain Apollo […]